NASDAQ: RGNXRegenxbio Inc Stock Ownership - Who owns Regenxbio?
Insider buying vs selling
Have Regenxbio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mitchell Chan | CFO | 2026-09-01 | 4,902 | $9.32 | $45.69kSell |
| Craig Malzahn | CTO | 2026-09-01 | 234 | $9.32 | $2.18kSell |
| Gregory Austin Ciongoli | Director | 2026-08-27 | 53,407 | $9.36 | $499.68kBuy |
| Gregory Austin Ciongoli | Director | 2026-08-26 | 49,196 | $9.14 | $449.70kBuy |
| Patrick J. Christmas | CLO;CStrat | 2026-08-01 | 4,699 | $9.69 | $45.53kSell |
| Steve Pakola | Med | 2026-08-01 | 7,468 | $9.69 | $72.36kSell |
| Steve Pakola | Chief Medical Officer | 2026-07-02 | 2,161 | $7.86 | $16.99kBuy |
| Steve Pakola | Chief Medical Officer | 2026-07-02 | 2,161 | $13.64 | $29.48kSell |
| Curran Simpson | Chief Executive Officer | 2026-07-01 | 6,818 | $13.09 | $89.25kSell |
| Steve Pakola | Chief Medical Officer | 2026-07-01 | 36,725 | $7.86 | $288.66kBuy |
RGNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RGNX insiders and whales buy or sell their stock.
RGNX Shareholders
What type of owners hold Regenxbio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Allan M. Fox | 10.48% | 6,915,528 | $54.49M | Insider |
| Fmr LLC | 3.65% | 2,406,547 | $18.96M | Insider |
| James E. Flynn | 2.04% | 1,344,042 | $10.59M | Insider |
| Kenneth T. Mills | 0.75% | 495,925 | $3.91M | Insider |
| Curran Simpson | 0.51% | 338,053 | $2.66M | Insider |
| Vittal Vasista | 0.37% | 246,534 | $1.94M | Insider |
| Olivier Danos | 0.34% | 226,348 | $1.78M | Insider |
| Patrick J. Christmas | 0.31% | 205,968 | $1.62M | Insider |
| Steve Pakola | 0.31% | 205,541 | $1.62M | Insider |
| Mitchell Chan | 0.19% | 122,815 | $967.78k | Insider |
RGNX vs Biotech Stocks
Regenxbio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.